Actively Recruiting
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Led by Albert Einstein Healthcare Network · Updated on 2025-07-10
24
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
Sponsors
A
Albert Einstein Healthcare Network
Lead Sponsor
M
Moss Rehabilitation Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.
CONDITIONS
Official Title
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Physician diagnosed idiopathic Parkinson's disease
- Any Hoehn and Yahr stage (1-4)
- Able to consent to participate in the study
- Agreeable to 45-60 minutes of high intensity gait training or physical therapy
- Sufficient upper extremity strength to use a front wheeled walker
- Self-reported walking or balance deficits
- Age over 18 years
- Able to tolerate standing upright for at least 15 minutes
- Weigh 220 pounds (100 kg) or less
- Height approximately between 5'0" and 6'4"
- Near normal range of motion in hips, knees, and ankles (able to stand up and straighten knees briefly or lie flat and straighten knees)
You will not qualify if you...
- Currently involved in another intervention study or physical therapy course of care
- Having another neurological disease besides Parkinson's
- Self-reported leg length difference
- Spinal instability
- Unresolved deep vein thrombosis
- Severe muscle or skeletal pain
- Open skin ulcers on areas contacting the exoskeleton or harness
- Pregnancy
- Cognitive impairments preventing following two-step commands or communicating pain or need to stop
- Requires assistance of more than one therapist to transfer safely
- Uncontrolled or severe orthostatic hypotension limiting standing tolerance
- Active heterotrophic ossification, hip dysplasia, or hip/knee alignment problems
- Having a colostomy
- History of long bone fractures due to osteoporosis
- Unable to maintain current Parkinson's medication regimen or recent medication changes
- Any condition the therapist considers harmful for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jefferson Moss-Magee Rehabilitation - Elkins Park
Elkins Park, Pennsylvania, United States, 19027
Actively Recruiting
Research Team
J
Jacqueline Brown, DPT
CONTACT
K
Kris Ferrara, DPT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here